Trethera, TRE-515, FDA Fast Track, KRAS G12C, KRAS Inhibitors, Non-Small Cell Lung Cancer, NSCLC, dCK, Deoxycytidine Kinase, Nucleoside Salvage Pathway

LOS ANGELES — October 1, 2026 Trethera Corporation announced that the U.S. Food and Drug Administration (FDA) has granted...